Our Team

Martin Devenport, PhD, MBA

Chief Operating Officer

Prior to joining OncoImmune, Dr. Devenport was VP for Business Strategy at Amplimmune Inc., where he oversaw all project management and operational activities, as well as business development, contracts and intellectual property. Dr. Devenport is experienced with all aspects of the drug development process, including research, development, GMP manufacturing, regulatory and clinical trials, and has managed a number of biotechnology programs that reached clinical stage development in oncology and autoimmune indications.

About Us

Based in Rockville, Maryland, OncoImmune is a
privately-held, clinical-stage biopharmaceutical
company that is actively engaged in the discovery
and development of biopharmaceuticals for the
treatment of cancer and autoimmune disease.

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.